The impact of lipid-lowering medications on coronary artery plaque characteristics

Atherosclerosis is the predominant cause of coronary artery disease. The last several decades have witnessed significant advances in lipid-lowering therapies, which comprise a central component of atherosclerotic cardiovascular disease prevention. In addition to cardiovascular risk reduction with dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulipati, Vishnu Priya, Alenghat, Francis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627965/
https://www.ncbi.nlm.nih.gov/pubmed/34877559
http://dx.doi.org/10.1016/j.ajpc.2021.100294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627965/
https://www.ncbi.nlm.nih.gov/pubmed/34877559
http://dx.doi.org/10.1016/j.ajpc.2021.100294

Ejemplares similares